Security key
00791X209
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 11,898,571
- Total 13F shares
- 1,271,217
- Share change
- -255,560
- Total reported value
- $585,730
- Price per share
- $0.76
- Number of holders
- 18
- Value change
- -$147,232
- Number of buys
- 7
- Number of sells
- 2
Report period
Q2 2025
Institutions
18
Top holders
10
AEON full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
AEON Biopharma, Inc. SEC filings
AEON Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00791X209
Recent filing periods:
Top shareholders of AEON - AEON Biopharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Jorey Chernett |
13D/G
|
Chernett Jorey |
9.9%
|
1,128,500
|
$564,250 | $0 | 27 May 2025 | |
| Dauntless Investment Group, LLC |
13F
13D/G
|
Company |
9.7%
from 13D/G
|
1,025,000
|
$593,988 | — | 31 Mar 2025 | |
| BIGGER CAPITAL FUND L P |
13D/G
|
Bigger Michael |
6.1%
|
4,900,000
|
$343,000 | $0 | 06 Jan 2025 | |
| PALMISANO ROBERT J |
13D/G
3/4/5
|
Robert J Palmisano · Director |
5.7%
|
2,265,000
|
$158,550 | $0 | 25 Jul 2024 | |
| L1 Capital Global Opportunities Master Fund, Ltd. |
13D/G
|
— |
4.1%
|
465,029
|
$32,552 | -$594,648 | 31 Mar 2025 | |
| Blue Owl Capital Holdings LP |
13D/G
13F
|
Company |
3.8%
|
3,049,361
|
$213,455 | $0 | 31 Dec 2024 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
3.8%
|
449,687
|
$260,594 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.03%
|
3,671
|
$2,128 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
2,957
|
$1,715 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
2,319
|
$1,342 | — | 31 Mar 2025 | |
| DUPONT CAPITAL MANAGEMENT CORP |
13F
|
Company |
0%
|
170
|
$99 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
150
|
$87 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
106
|
$61 | — | 31 Mar 2025 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
100
|
$58 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
90
|
$52 | — | 31 Mar 2025 | |
| WOLFF WIESE MAGANA LLC |
13F
|
Company |
0%
|
67
|
$39 | — | 31 Mar 2025 | |
| MAI Capital Management |
13F
|
Company |
0%
|
58
|
$34 | — | 31 Mar 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0%
|
33
|
$14 | — | 31 Mar 2025 | |
| GHP Investment Advisors, Inc. |
13F
|
Company |
0%
|
15
|
$9 | — | 31 Mar 2025 | |
| DANSKE BANK A/S |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Mar 2025 | |
| Priveterra Sponsor, LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
14,013,205
mixed-class rows
|
$138,891,630 | — | 21 Jul 2023 | |
| Strathspey Crown Holdings Group, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,031,773
|
$20,317,730 | — | 11 Aug 2023 | |
| BARCLAYS PLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
702,645
|
— | — | 20 Feb 2023 | |
| Jost Fischer |
3/4/5
|
Director |
—
mixed-class rows
|
671,636
mixed-class rows
|
$130,057 | — | 21 May 2025 | |
| Marc Forth |
3/4/5
|
Director |
—
mixed-class rows
|
2,376,979
mixed-class rows
|
— | — | 21 May 2025 | |
| Eric G. Carter |
3/4/5
|
Director |
—
mixed-class rows
|
440,872
mixed-class rows
|
— | — | 21 May 2025 | |
| Shelley B. Thunen |
3/4/5
|
Director |
—
mixed-class rows
|
440,872
mixed-class rows
|
— | — | 21 May 2025 |
Institutional Holders of AEON Biopharma, Inc. - Common Stock (AEON) as of Q2 2025
As of 30 Jun 2025,
AEON Biopharma, Inc. - Common Stock (AEON) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,271,217 shares.
The largest 10 holders included
Dauntless Investment Group, LLC, HRT FINANCIAL LP, Blue Owl Capital Holdings LP, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., BANK OF AMERICA CORP /DE/, CITIGROUP INC, DUPONT CAPITAL MANAGEMENT CORP, and MORGAN STANLEY.
This page lists
18
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
15
Q2 2025 holders
18
Holder diff
3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.